Childhood and Adolescent Vaccination in Alternative Settings

Hofstetter, Annika M.; Schaffer, Stanley J.

doi:10.1016/j.acap.2021.02.001

Cited by 26 publications

(12 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The VFC program covers the cost of all recommended vaccines for eligible children; it is imperative that this program retain an adequate supply of participating vaccination providers and that families in need are aware of how to access it. Establishment of alternative vaccination settings such as pharmacies, emergency departments, hospitals, and outpatient subspecialty clinics might help address accessibility issues for underserved communities ( 8 ).…”

Section: Discussionmentioning

confidence: 99%

Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021

Hill

Chen

Elam–Evans

et al. 2023

MMWR Morb. Mortal. Wkly. Rep.

View full text Add to dashboard Cite

Millions of young children are vaccinated safely in the United States each year against a variety of potentially dangerous infectious diseases (1). The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination against 14 diseases during the first 24 months of life* (2). This report describes vaccination coverage by age 24 months using data from the National Immunization Survey-Child (NIS-Child). † Compared with coverage among children born during 2016-2017, coverage among children born during 2018-2019 increased for a majority of recommended vaccines. Coverage was >90% for ≥3 doses of poliovirus vaccine (93.4%), ≥3 doses of hepatitis B vaccine (HepB) (92.7%), ≥1 dose of measles, mumps, and rubella vaccine (MMR) (91.6%), and ≥1 dose of varicella vaccine (VAR) (91.1%); coverage was lowest for ≥2 doses of hepatitis A vaccine (HepA) (47.3%). Vaccination coverage overall was similar or higher among children reaching age 24 months during March 2020 or later (during the COVID-19 pandemic) than among those reaching age 24 months before March 2020 (prepandemic); however, coverage with the combined 7-vaccine series § among children living below the federal poverty level or in rural areas decreased by 4-5 percentage points during the pandemic (3). Among children born during 2018-2019, coverage disparities were observed by race and ethnicity, poverty status, health insurance status, and Metropolitan Statistical Area (MSA) residence. Coverage was typically higher among privately insured children than among children with other insurance or no insurance. * Vaccination against COVID-19 was recommended for children aged 6 months-4 years in June 2022 (https://www.cdc.gov/vaccines/acip/recs/grade/ covid-19-moderna-pfizer-children-vaccine-etr.html). Children in this report were either aged >4 years during June 2022 (some were eligible for COVID-19 vaccine at age ≥5 years, but vaccine history was not ascertained past age 35 months), or data on vaccine histories were collected before 2022. † Estimates for U.S. Department of Health and Human Services regions, states, selected local areas, and the territories of Guam and Puerto Rico can be found online (https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/ data-reports/index.html). Certain local areas that receive federal Section 317 immunization funds are sampled separately and included in the NIS-Child sample every year (

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021

Hill

Chen

Elam–Evans

et al. 2023

MMWR Morb. Mortal. Wkly. Rep.

View full text Add to dashboard Cite

show abstract

“…While parental views on adolescent and paediatric vaccination have been widely studied, the views of adolescent healthcare professionals have received less attention despite the fact that their recommendations play a key role in vaccine uptake. 13–16 , 34 Although our focus on healthcare professionals was a strength, our results reflect an indirect measure of healthcare professionals’ perceptions of parents’ views. While it would have been ideal to align these results with the attitudes and beliefs of parents who interacted with respondents of our survey, the survey was not designed to accomplish this.…”

Section: Discussionmentioning

confidence: 86%

Recommending COVID-19 vaccination for adolescents in primary care

et al. 2022

View full text Add to dashboard Cite

Background COVID-19 vaccines are available for adolescents in the United States, but many parents are hesitant to have their children vaccinated. The advice of primary care professionals strongly influences vaccine uptake. Objective We examined the willingness of primary care professionals (PCPs) to recommend COVID-19 vaccination for adolescents. Methods Participants were a national sample of 1,047 US adolescent primary care professionals. They participated in an online survey in early 2021, after a COVID-19 vaccine had been approved for adults but before approval for adolescents. Respondents included physicians (71%), advanced practice providers (17%), and nurses (12%). We identified correlates of willingness to recommend COVID-19 vaccination for adolescents using logistic regression. Results The majority (89%) of respondents were willing to recommend COVID-19 vaccination for adolescents, with advanced practice providers and nurses being less likely than paediatricians to recommend vaccination (84% vs. 94%, aOR 0.47, 95% CI 0.23–0.92). Respondents who had received at least one dose of a COVID-19 vaccine were more likely to recommend adolescent vaccination (92% vs. 69%, aOR 4.20, 95% CI 2.56–6.87) as were those with more years in practice (94% vs. 88%, aOR 2.93, 95% CI 1.79–4.99). Most respondents (96%) said they would need some measure of support in order to provide COVID-19 vaccination to adolescents, with vaccine safety and efficacy information being the most commonly cited need (80%). Conclusion Adolescent primary care professionals were generally willing to recommend COVID-19 vaccination. However, most indicated a need for additional resources to be able to administer COVID-19 vaccines at their clinic.

show abstract

“…Thus, geographic distance to healthcare facilities seems to remain a barrier for families to access vaccination in HICs in the twenty-first century [3]. Suggested solutions to simplify access to vaccination included allowing vaccination in alternative settings such as pharmacies, schools, or by private nurses [37]. Vaccination of children directly in childcare settings during French targeted vaccination campaigns following local outbreaks (e.g., MenC) has been successful [38].…”

Section: Main Results and Interpretationmentioning

confidence: 99%

Determinants of incomplete vaccination in children at age two in France: results from the nationwide ELFE birth cohort

et al. 2022

View full text Add to dashboard Cite

Incomplete vaccination in the pediatric population is a growing public health issue in high-income countries, but its determinants are poorly understood. Their identification is necessary to design target actions that can improve vaccination uptake. Our aim was to assess the determinants of incomplete vaccination in two-year-old children in France. Among the 18,329 children included in the 2011 ELFE French nationwide population-based birth cohort, we selected those for whom vaccination status was available at age two years. Incomplete vaccination was defined as ≥ 1 missing dose of recommended vaccines. Potential determinants of incomplete vaccination were identified by using logistic regression, taking into account attrition and missing data. Of the 5,740 (31.3%) children analyzed, 46.5% (95% confidence interval [CI] 44.7–48.0) were incompletely vaccinated. Factors independently associated with incomplete vaccination were having older siblings (adjusted odds ratio 1.18, 95% CI [1.03–1.34] and 1.28 [1.06–1.54] for one and ≥ 2 siblings, respectively, vs. 0), residing in an isolated area (1.92 [1.36–2.75] vs. an urban area), parents not following health recommendations or using alternative medicines (1.81 [1.41–2.34] and 1.23 [1.04–1.46], respectively, vs. parents confident in institutions and following heath recommendations), not being visited by a maternal and child protection service nurse during the child’s first two months (1.19 [1.03–1.38] vs. ≥ 1 visit), and being followed by a general practitioner (2.87 [2.52–3.26] vs. a pediatrician). Conclusions : Incomplete vaccination was highly prevalent in the studied pediatric population and was associated with several socio-demographic, parental, and healthcare service characteristics. These findings may help in designing targeted corrective actions. What is Known: • Incomplete vaccination in the pediatric population is a growing public health issue in high-income countries. • The partial understanding of the determinants of incomplete vaccination precludes the design of effective targeted corrective actions. What is New: • High prevalence of incomplete vaccination at age two years in France. • Incomplete vaccination was independently associated with several socio-demographic, parental, and healthcare service characteristics. Supplementary Information The online version contains supplementary material available at 10.1007/s00431-022-04733-z.

show abstract

Childhood and Adolescent Vaccination in Alternative Settings

Cited by 26 publications

References 48 publications

Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021

Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021

Recommending COVID-19 vaccination for adolescents in primary care

Determinants of incomplete vaccination in children at age two in France: results from the nationwide ELFE birth cohort

Contact Info

Product

Resources

About